C P Peter
Overview
Explore the profile of C P Peter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seletzky J, Otten K, Lotter S, Fricke J, Peter C, Maier H, et al.
Biotech Histochem
. 2006 Nov;
81(4-6):133-8.
PMID: 17129996
We introduce a generic, simple, and inexpensive method for performing microbiological, enzymatic, or inorganic catalysis with solids using standard histology and microbiology laboratory equipment. Histology cassettes were used to standardize...
2.
Molon-Noblot S, LAROQUE P, Prahalada S, Stabinski L, Peter C, DUPRAT P, et al.
Toxicol Pathol
. 2000 Aug;
28(4):510-7.
PMID: 10930036
Porcine growth hormone was administered subcutaneously to beagle dogs at doses of 0.025, 0.1, and 1 IU/kg/d for 14 weeks, markedly elevating serum growth hormone (GH) and insulin-like growth factor-1...
3.
Peter C, Handt L, Smith S
Dig Dis Sci
. 1998 Sep;
43(9):1998-2002.
PMID: 9753265
Animal studies were done using an in vivo dog model to examine the possible mechanism for the esophageal adverse events reported with alendronate sodium tablets. These studies showed that under...
4.
Peter C, Kindt M, Majka J
Dig Dis Sci
. 1998 May;
43(5):1009-15.
PMID: 9590415
Bisphosphonates have generally few clinical adverse effects, the most common being gastrointestinal disturbances. It is generally believed that bisphosphonates with a primary amine are more irritating to the gastrointestinal tract...
5.
Molon-Noblot S, LAROQUE P, Prahalada S, Stabinski L, Hoe C, Peter C, et al.
Toxicol Pathol
. 1998 Apr;
26(2):207-12.
PMID: 9547857
Administration of growth hormone (GH) results in increased body weight gain in dogs. Increased body weight gain is believed to be a result of the trophic effect of GH on...
6.
Morphological changes in the pituitary gland of dogs chronically exposed to exogenous growth hormone
LAROQUE P, Molon-Noblot S, Prahalada S, Stabinski L, Hoe C, Peter C, et al.
Toxicol Pathol
. 1998 Apr;
26(2):201-6.
PMID: 9547856
Growth hormone (GH) synthesis and release from the pituitary is regulated by hypothalamic releasing hormone, insulin-like growth factor-1 (IGF-1), and somatostatin. However, the potential effects of pharmacological doses of exogenous...
7.
Prahalada S, Stabinski L, Chen H, Morrissey R, De Burlet G, Holder D, et al.
Toxicol Pathol
. 1998 Apr;
26(2):185-200.
PMID: 9547855
The purpose of this study was to evaluate the pharmacological and toxicological effects of exogenous GH administration in normal adult dogs. Because porcine GH (pGH) is structurally identical to canine...
8.
Prahalada S, Tarantal A, Harris G, Ellsworth K, Clarke A, Skiles G, et al.
Teratology
. 1997 Feb;
55(2):119-31.
PMID: 9143092
In genetic male fetuses, dihydrotestosterone (DHT) plays an important role in normal prostatic and external genital differentiation. The enzyme steroid 5-alpha reductase (5 alpha R) catalyzes the conversion of testosterone...
9.
Storer R, Gordon L, Barnum J, Sopar K, Peter C
Toxicol Appl Pharmacol
. 1996 Jun;
138(2):219-30.
PMID: 8658523
The effects of alkaline pH and elevated sodium concentrations in culture medium on rat bladder explants for 1, 2, and 3 weeks were investigated by continuous BrdU labeling and histopathology....
10.
Peter C, Cook W, Nunamaker D, Provost M, Seedor J, Rodan G
J Orthop Res
. 1996 Jan;
14(1):74-9.
PMID: 8618170
To examine the effect of alendronate (4-amino-1-hydroxybutylidene bisphosphonate) on fracture repair, the drug was given to mature beagle dogs orogastrically at 2 mg/kg/day for 9 weeks preceding fracture. 16 weeks...